How does COVID-19 affect prostate cancer?

Published Date: 14 Mar 2023

As the COVID-19 pandemic spreads, access to and delivery of health services has been disrupted like never before. How has it affected the treatment of prostate cancer?

Read Full News

Latest News

Testosterone Is Back; Have We Learned From Our Mistakes?

A new push to prescribe testosterone replacement therapy led this cardiologist to review the cardiovascular risk data.

The Pitt Season 2: EM Docs Tackle Tough Diagnoses (Part 3)

Drs Robert Glatter and Amy Faith Ho continue their review of The Pitt season 2, tackling retinal artery occlusion, phytophotodermatitis, and ovarian torsion. They unpack clinical accuracy, informed consent, and bias in emergency care.

Conference MDAngle: AUA 2026 Metastatic Prostate Cancer

Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.

AUA 2026: Previewing Metastatic Prostate Cancer Updates

Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary management.

Updates in Ovarian Cancer From SGO 2026

Landmark survival gains in ROSELLA and KEYNOTE-B96 in platinum-resistant disease plus pivotal data in low-grade serous ovarian cancer are highlights from SGO 2026, reported by Dr Amelia Jernigan.

A Primary Care Primer on Alzheimer’s Blood Tests

Alzheimer’s management may slowly be making its way to primary care, so The Curbsiders unpack the latest on blood-based biomarkers and antiamyloid therapies.

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Latest News

A new push to prescribe testosterone replacement therapy led this cardiologist to review the cardiovascular risk data.

Drs Robert Glatter and Amy Faith Ho continue their review of The Pitt season 2, tackling retinal artery occlusion, phytophotodermatitis, and ovarian torsion. They unpack clinical accuracy, informed consent, and bias in emergency care.

Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.

Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary management.

Landmark survival gains in ROSELLA and KEYNOTE-B96 in platinum-resistant disease plus pivotal data in low-grade serous ovarian cancer are highlights from SGO 2026, reported by Dr Amelia Jernigan.

Alzheimer’s management may slowly be making its way to primary care, so The Curbsiders unpack the latest on blood-based biomarkers and antiamyloid therapies.

News All Time

Woman With Lateral Neck Cyst From Fourth Branchial Cleft

An uncommon congenital fourth branchial cleft cyst presents after exercise as a painless, mobile posterior neck mass, highlighting the need for prompt imaging and surgery.

A Man With Severe Gallbladder Dyskinesia

Severe gallbladder dysfunction may present without stones: a case of EF 2% on HIDA in a patient with fatty-meal pain whose pathology showed mild chronic cholecystitis.

Early PsA Detection: Biomarkers and Genetics

Dr Vinod Chandran discusses biomarkers, genetics, and clinical features that assess risk for psoriatic arthritis.

Precision Nutrition for Better Clinical Outcomes

Precision nutrition integrates genetics, the gut microbiome, metabolomics and lifestyle data to tailor dietary therapy promising better clinical outcomes.

When to Operate on a Pancreatic Cyst

More incidental pancreatic cysts are being found with modern imaging; physicians must weigh MRI surveillance against high risk surgery based on size, growth, and duct dilation.

S3 Episode 2: Endometrial Cancer Research: The Past, Present, and Future

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

S3 Episode 1: Phase 3 Trial ADCs in Endometrial Cancer

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

Lithium Beyond Bipolar: A New Role in Brain Health

Could lithium be more than a mood stabilizer? Dr James Greenblatt examines its emerging role in brain resilience and cognitive health.

The Thyroid Cancer Dilemma: Doing More Isn’t Always Better

With rising thyroid cancer rates but stable mortality, clinicians must weigh the costs of overdiagnosis to ensure precision care over unnecessary intervention.

S1 Episode 1: Rethinking Rhythm Control in ATTR-CM

Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.

S1 Episode 2: Can Early Genetic Testing Change ATTR-CM Outcomes?

Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.

Chest Plaque Reveals Dermatofibrosarcoma in a Man

Dermatofibrosarcoma protuberans can masquerade as a benign plaque — this case requires biopsy of a 10 × 8 cm anterior chest lesion to confirm spindle cell sarcoma and guide curative surgical excision.

New ‘Breathing’ Lung-On-Chip Surprises Against Tuberculosis

Four types of lung cells — including immune cells — function together on a chip environment that simulates respiration and inhibits tuberculosis growth.

S2 Episode 6: PCR in Breast Cancer and HER2

Drs Kathy Miller and Lajos Pusztai discuss predicting which patients will have a PCR, and the impact this has on new treatments or reducing the intensity of treatments.

Therapeutic Drug Monitoring Widely Variable in Ped Rheum

In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.

Treat the Patient, Not the Biomarker: The ctDNA Dilemma

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Recommended News For You

From Pathology to Precision: The Story of Leukemia Therapy

Increased Exercise May Lower the Risk of Prostate Cancer.

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

Recommended Articles For You

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances 

Neutrophil Profiling and AI Rewrites Cancer Diagnosis 

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

2.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

3.

Clinical trial is testing whether heavy lifting could combat cancer side effects

4.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

5.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

1.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

2.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology

5.

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XIII

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot